Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H13BrN2O6 |
Molecular Weight | 349.135 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)N2C=C(\C=C\Br)C(=O)NC2=O
InChI
InChIKey=GCQYYIHYQMVWLT-HQNLTJAPSA-N
InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8+,10-/m1/s1
Molecular Formula | C11H13BrN2O6 |
Molecular Weight | 349.135 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/2549386Curator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/1653394
http://www.chemdrug.com/article/8/3284/16419323.html
Sources: http://www.ncbi.nlm.nih.gov/pubmed/2549386
Curator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/1653394
http://www.chemdrug.com/article/8/3284/16419323.html
SORIVUDINE (BV-araU) is an Anti-Herpes Virus Drugs, which was Withdrawn in 1995. Aantiviral action of BV-araU against VZV (varicella-zoster virus) and herpes simplex virus type 1 (HSV-1) is based on the inhibition of DNA synthesis in herpesvirus-infected cells.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: synthesis of virus DNA Sources: http://www.ncbi.nlm.nih.gov/pubmed/2549386 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils. | 1981 Jul |
|
Antiherpes activity of [E]-5-(1-propenyl)-2'-deoxyuridine and 5-(1-propenyl)-1-beta-D-arabinofuranosyluracil. | 1981 Nov |
|
Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. | 1981 Sep |
|
Comparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replication. | 1988 Jul |
|
Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells. | 1988 Jul |
|
Effects of various nucleosides on antiviral activity and metabolism of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus types 1 and 2. | 1988 Oct |
|
(E)-5-(2-bromovinyl)uridine requires phosphorylation by the herpes simplex virus (type 1)-induced thymidine kinase to express its antiviral activity. | 1989 Jun 15 |
|
Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus type 1 infection in immunosuppressed mice. | 1990 Dec |
|
Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds. | 1990 Dec |
|
Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro. | 1990 Jul |
|
Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) on experimental infections in mice with herpes simplex virus type 1 strains of different degrees of virulence. | 1990 May |
|
Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogues and related compounds. | 1992 May 15 |
|
Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes. | 1996 Apr |
|
Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus. | 1997 Aug |
|
A facile, alternative synthesis of 4'-thioarabinonucleosides and their biological activities. | 1997 Jul 4 |
|
Anti-herpesvirus activity profile of 4'-thioarabinofuranosyl purine and uracil nucleosides and activity of 1-beta-D-2'-fluoro-4'-thioarabinofuranosyl guanine and 2,6-diaminopurine against clinical isolates of human cytomegalovirus. | 1998 Aug |
|
Selective activity of various antiviral compounds against HHV-7 infection. | 1999 Aug |
|
Synthesis of novel 4'-C-methyl-pyrimidine nucleosides and their biological activities. | 1999 Mar 22 |
|
Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitors. | 2001 May 21 |
|
In vitro activity of potential anti-poxvirus agents. | 2003 Jan |
|
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir? | 2004 Mar |
|
Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase. | 2004 Mar 19 |
|
Synthesis and antiviral activities of 1'-carbon-substituted 4'-thiothymidines. | 2004 Oct 15 |
|
Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides. | 2005 Mar |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/8391248
for mice: 5% BV-araU (SORIVUDINE) cream given 4 times daily for 5 days starting 1 day after inoculation
Route of Administration:
Topical
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/1653394
The inhibitory effect of BV-araU (SORIVUDINE) on DNA synthesis in human embryonic lung cells infected with varicella-zoster virus (VZV) or herpes simplex virus type 1 (HSV-1) was compared with that of acyclovir. he inhibitory concentration of BV-araU for DNA synthesis in VZV-infected cells was one-thousandth of that of acyclovir.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:57:30 GMT 2023
by
admin
on
Sat Dec 16 15:57:30 GMT 2023
|
Record UNII |
C7VOZ162LV
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
92295
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
||
|
NCI_THESAURUS |
C281
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
||
|
NCI_THESAURUS |
C2019
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB11998
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
DTXSID6057827
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
C7VOZ162LV
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
SORIVUDINE
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
CHEMBL70046
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
77181-69-2
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
SUB10605MIG
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
100000083796
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
6695
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
EE-52
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
2463
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
5282192
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
m10123
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | Merck Index | ||
|
C031368
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY | |||
|
C1460
Created by
admin on Sat Dec 16 15:57:30 GMT 2023 , Edited by admin on Sat Dec 16 15:57:30 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |